Who owns ABIOMED?

Key details on ABIOMED (Ticker: ABMD)

Who owns ABIOMED?

Is ABMD a good stock to own? Find out who bought ABIOMED, who sold ABIOMED (ABMD) stock, and who holds a large position in ABIOMED.

Fund Name Number of Shares Share Valuation As Of
Vanguard 12.72M $1.18B Sept. 30, 2015
PRIMECAP Management Company 5.67M $525.77M Sept. 30, 2015
Palo Alto Investors 2.83M $262.23M Sept. 30, 2015
BlackRock Fund Advisors 2.50M $231.50M Sept. 30, 2015
Essex Woodlands Health Ventures 2.15M $141.32M June 30, 2015
Jackson Square Partners 1.83M $120.22M June 30, 2015
Tiger Global Management 1.69M $41.96M Sept. 30, 2014
Blue Mountain Capital Management 1.61M $41.87M March 31, 2014
Wellington Management Company 1.31M $93.87M March 31, 2015
Next Century Growth Investors 1.17M $29.16M Sept. 30, 2014
Name Goodman & Company, Investment Counsel 1.14M $104.51M Sept. 30, 2015
Millennium Management 1.14M $28.31M Sept. 30, 2014
William Blair $ Company 1.10M $72.28M June 30, 2015
Macquarie 1.10M $102.00M Sept. 30, 2015
Cortina Asset Management 1.06M $26.43M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 1.05M $26.06M Sept. 30, 2014

Who sold ABIOMED?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management March 31, 2011 1.17M $17.02M
Portolan Capital Management March 31, 2011 1.10M $15.92M